Clinical trial delays often begin long before execution, hidden within protocol design, site selection, operational planning, and data readiness. This fact sheet explores how IQVIA Predictive Clinical Development helps sponsors identify early signals of risk, make informed decisions sooner, and remove barriers before they impact timelines. By shifting from reactive to proactive trial planning, organizations can reduce start-up time, minimize delays between phases, and keep development programs moving forward with greater speed and confidence.